ENTWISTLE & CAPPUCCI LLP APPOINTED LEAD COUNSEL IN SECURITIES CLASS ACTION INVOLVING CEREVEL THERAPEUTICS HOLDINGS, INC. AND RELATED DEFENDANTS

June 24, 2025

On June 23, 2025, the United States District Court for the District of Delaware appointed Entwistle & Cappucci LLP as Lead Counsel in the securities action against Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) and related defendants.

The case is brought on behalf of all persons or entities that: (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel during the period from October 11, 2023 through August 1, 2024, inclusive, and thus were damaged by defendants’ violations of Section 10(b) of the Securities Exchange Act of 1934 (“Exchange Act”); (b) sold shares of Cerevel stock contemporaneously with Bain Capital Investors, LLC’s (“Bain”) purchase of shares on or about October 16, 2023 and thus were damaged by Bain’s violations of Section 20A of the Exchange Act; and/or (c) held shares of Cerevel as of January 8, 2024 (the “Record Date”) and were entitled to vote on the merger (“Merger”) of Cerevel and AbbVie Inc. (”AbbVie”) and thus were damaged by defendants’ violations of Section 14(a) of the Exchange Act.

The action seeks to recover damages resulting from defendants’ alleged omissions and other wrongdoing in connection with Cerevel’s October 2023 secondary stock offering through the close of the Merger.  Specifically, the action alleges defendants conducted the October 2023 stock offering at an artificially depressed price by withholding that AbbVie was interested in acquiring Cerevel at a significant premium.  Defendant Bain allegedly orchestrated this scheme to acquire millions of shares in the offering at an artificially depressed price, locking in a profit of more than $120 million when the Merger was announced just two months later.  Defendants continued to mislead investors by omitting the true timing of AbbVie’s interest in acquiring the Company, and the real reason for the October offering in the operative proxy statement.

Lead Counsel is preparing a consolidated complaint to be filed on or before August 13, 2025.